Apollo Hospitals Shares Q3 Results

Apollo Hospitals Shares Q3 Results

Corporate Action
by 5paisa Research Team Last Updated: 2022-08-08T18:46:27+05:30

Apollo Hospitals, the largest private sector hospital chain in India, reported another quarter of stellar results. The stock has been a top performer in the last couple of years with most of the capital expansion done and dusted and incremental revenues directly contributing to the bottom line. Dec-21 quarter was another quarter of solid growth across verticals for Apollo Hospitals.


Here is a Gist of  Apollo Hospitals Financial Numbers for Q3
 

Rs in Crore

Dec-21

Dec-20

YOY

Sep-21

QOQ

Total Income (Rs cr)

₹ 3,638.93

₹ 2,759.85

31.85%

₹ 3,717.07

-2.10%

Operating Profit (Rs cr)

₹ 438.03

₹ 265.25

65.14%

₹ 470.24

-6.85%

Net Profit (Rs cr)

₹ 228.37

₹ 130.43

75.09%

₹ 247.82

-7.85%

Diluted EPS (Rs)

₹ 15.88

₹ 9.38

 

₹ 17.24

 

Operating Margins

12.04%

9.61%

 

12.65%

 

Net Margins

6.28%

4.73%

 

6.67%

 

 

For the Dec-21 quarter, Apollo Hospitals reported 31.9% higher sales revenues at Rs.3,639 crore on a YoY consolidated basis. Let us look at how the various verticals performed during the quarter. During the December 2021 quarter, revenues from the predominant core healthcare services business saw growth of 40.3% YoY at Rs.2,024 crore. Overall revenues were marginally lower on a sequential basis by just about -2.10%.

Among other verticals, other than core healthcare, the pharmacy distribution vertical saw revenues grow of a healthy 16% YoY at Rs.1,307 crore. In addition, the clinics verticals also grew revenues by a healthy 59% YoY at Rs.313 crore. The retail pharmacy business of Apollo has been transferred to Apollo Pharmacy and hence does not figure among verticals. During Q3, Apollo raised Rs.1,170 crore via QIP placement of 46.6 lakh shares at a price of Rs.2,511.

Let us now turn to the operating performance of Apollo for the third quarter. For the Dec-21 quarter, operating profits increased by 65.14% on a YoY basis Rs.438.03 crore. However, on a sequential basis, the operating profits were lower by -6.85% due to short term cost pressures. In terms of the operating performance, the principal healthcare services vertical saw operating profits increasing by a healthy 102% you at Rs.382 crore.

Among other verticals, the clinics vertical was the surprise package as operating profits grew almost 4-fold at Rs.25 crore, albeit on a smaller base. Pharmacy distribution business saw operating profits fall -55% at Rs.32.10 crore YoY. Cost of materials and consumables were up 35% YoY but largely got offset by inventory efficiency gains. Operating margins in Q3 was up from 9.61% in Dec-20 quarter to 12.04% in the Dec-21 quarter. However, the OPM was 61 bps lower on sequential basis.

Now we look at the bottom line. Net Profits for the Dec-21 quarter were up 75.09% at Rs.228.37 crore in the quarter due to the strong operating performance of Apollo Hospitals getting transmitted to the bottom line. Even the expenses component of Apollo escalated sharply in the quarter . PAT margins were up from 4.73% in the Dec-20 quarter to 6.28% in the Dec-21 quarter. However, PAT margins were lower by 49 bps on sequential basis.


Start Investing in 5 mins*

Get Benefits worth 2100* | Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.


Open Free Demat Account

& get benefits worth 2100*

Resend OTP
Please Enter OTP
  • Have Promo code?
  • Use code ACT2100
Enter Promo code
Account belongs to

By proceeding, you agree to the T&C.

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number